16.04.2012 • News

KazMunaiGas EP Q1 Oil Production Falls 5%

KazMunaiGas Exploration Production said on Monday it may cut its crude oil production forecast for the year after first-quarter output fell below target due to adverse weather conditions at oilfields in western Kazakhstan.

KazMunaiGas EP, the London-listed arm of Kazakh state oil and gas company KazMunaiGas, said in a statement that meeting full-year production targets at two major subsidiary companies "may be more challenging than previously anticipated".

The company said it produced 3.03 million tons, or 249,000 barrels per day, of crude oil in the first quarter of 2012. That was 5% less than in the same period last year.

Combined output at its major Uzenmunaigas and Embamunaigas subsidiaries fell 9 % year-on-year to 1.91 million tons, or 156,000 barrels per day, in the first three months of 2012. That was about 7 % short of its quarterly plan.

Combined production at the two fields has been forecast at 8.62 million tons for the entire year. The company said it still aimed to meet this target, but that second-quarter results would determine whether or not it would revise its forecast.

KazMunaiGas EP's net profit declined 11% last year due mainly to a strike at oilfields including Uzenmunaigas, which eventually erupted into Kazakhstan's worst violence in decades.

The company has set its full-year 2012 production target at 13.01 million tons, or 265,000 barrels per day.

KazMunaiGas EP said its share in first-quarter production from the Kazgermunai, CCEL and PetroKazakhstan joint ventures rose by 4% year-on-year to 1.12 million tons, or 93,000 barrels per day.

In a separate statement, the company said its proved plus probable reserves, excluding its joint venture stakes, totalled 225.82 million tons, or 1.66 billion barrels, as of Dec. 31.

Its reserves were assessed by independent auditor Gaffney, Cline & Associates. Its proved plus probable reserves replacement ratio in 2011 was 21%, the company said.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.